RGEN

REPLIGEN CORP

Healthcare | Mid Cap

$0.45

EPS Forecast

$184.7

Revenue Forecast

Announcing earnings for the quarter ending 2025-09-30 soon
REPLReplimune Group IncCRSPCrispr Therapeutics AgDNLIDenali Therapeutics IncHALOHalozyme Therapeutics IncIOVAIovance Biotherapeutics IncNBIXNeurocrine Biosciences IncNVAXNovavax IncTECHBio-techne CorpMRNAModerna Inc